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AIMS: We investigated the cross-sectional associations of Plasmodium infection (PI) with
fasting glucose (FG) and glycated hemoglobin (HbA1c) in malaria-endemic south-central
Coˆte d’Ivoire.
Methods: We studied 979 participants (non-pregnant; no treated diabetes; 51% males; 18–
87 years) of the Coˆte d’Ivoire Dual Burden of Disease study. Fasting venous blood was
obtained for PI, FG, and HbA1c assessment. We defined PI as a positive malaria rapid diag-
nostic test (RDT) or microscopic identification of Plasmodium species. We applied multivari-
able linear regressions to assess beta coefficients (b) and 95% confidence intervals (CIs) of PI
positivity for FG and HbA1c independent of diabetes risk factors.
Results: Prevalence of PI was 10.1% (5.5% microscopy; 9.7% RDT) without clinical fever.
Prevalence of FG-based prediabetes (45.8%) and diabetes (3.6%) were considerably higher
than HbA1c-based values (2.7% and 0.7%, respectively). PI was independently associated
with FG among participants with higher body temperature (b 0.34, 95% CI 0.06–0.63, phetero-
geneity = 0.028), or family history of diabetes (b 0.88, 95% CI 0.28–1.47, pheterogeneity = 0.009).
Similar patterns observed with HbA1c were obliterated on accounting for FG. We also
observed consistent associations with parasite density.
Conclusions: FG-based diabetes diagnosis in the presence of asymptomatic PI may misclas-
sify or overestimate diabetes burden in malaria-endemic settings. Longitudinal studies are
needed to confirm these findings and determine the risk for diabetes.
 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).x, CH-4002
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The rising rates of non-communicable diseases (NCDs) in a
background of prevalent infectious diseases, and in the con-
text of weak health systems in low- andmiddle-income coun-
tries (LMICs) have sparked interest on the potential role of
common infections as risk factors for NCDs [1–4]. LMICs
now have the greatest burden of mortality for diabetes world-
wide, in part because of delayed diagnosis [5]. Diabetes is of
particular interest regarding a potential link to infections
because of its association with altered immunity and
inflammation.
Inflammatory responses to repeated infections with
malaria parasites (Plasmodium species) may lead to sustained
physiological changes that increase diabetes susceptibility [6].
Plasmodium infection (PI) induces systemic inflammation via
the release of pyrogenic cytokines, including interleukin IL-
1b [7] upon activation of inflammatory pathways such as
NLRP3 inflammasome [8], which are also characteristic of
type 2 diabetes [9]. Pro-inflammatory blood markers such as
circulating C-reactive protein, IL-1b, IL-6, IL-8, and IL-10 were
associated with both malaria severity [10] and insulin resis-
tance [11]. IL-6 was higher in adults from a malaria-endemic
setting than in their age-adjusted western counterparts [6].
In utero malaria is thought to direct fetal physiological path-
ways toward insulin resistance [12] and impaired fasting glu-
cose (FG) in adolescence [13].
On the other hand, there are aspects that complicate
the investigation of repeated malaria infection as a risk
factor for diabetes. First, the stress-related glycemic
responses to acute malaria infections may complicate its
interpretation as an indicator for underlying diabetes in
epidemiologic, screening, and diagnostic contexts in
malaria-endemic settings. We have previously produced
evidence on the need to postpone diagnosing underlying
diabetes in tuberculosis patients until the end of treatment
[14]. Fever, a cardinal symptom of malaria, like tuberculo-
sis, induces stress-related hyperglycemia [14,15]. Second,
diabetes patients are more prone to developing infections
in general [16]. A higher prevalence of P. falciparum infec-
tion was found in participants with diabetes compared to
those without diabetes [17], and participants with diabetes
or obesity were reported to be at higher risk for severe
malaria [18].
There is a general lack of population-based, even cross-
sectional epidemiologic studies that investigate the associa-
tion of PI, which is more prevalent in the asymptomatic
form, with parameters of glycemic control or diabetes [3].
Population-based evidence on this link is therefore war-
ranted for a deeper understanding of the diabetogenic effect
of asymptomatic and potentially chronic carriage of PI. We
investigated the association between PI and markers of gly-
cemic control, including FG and glycated hemoglobin
(HbA1c) in a population-based, malaria-endemic setting of
south-central Coˆte d’Ivoire [1,19,20]. We considered effect
modification by hypothesized susceptibility factors to better
differentiate the acute vs. longer-term associations of PI with
glycemic control.2. Materials and methods
2.1. Study population
This study was carried out in 2017 in the frame of the Coˆte
d’Ivoire Dual Burden of Disease (CoDuBu) study, which
recruited 1019 adults selected at random, to investigate the
concomitance of common infections and NCDs, and their
molecular determinants [1,4] The CoDuBu study was done
within the Taabo health and demographic surveillance system
(HDSS) [19], which is equivalent to a civil registration system
that allows random sampling from the population. The
detailed study protocol, including sampling procedure, is
described elsewhere [1]. In brief, we estimated that we would
need at least 976 participants given an expected malaria-
diabetes cooccurrence rate (assuming independence) of 2%,
an errormargin of 1%, and a non-response rate of 30%. Toward
reaching this sample size,wefirst selected threeout of 14HDSS
main villages and town (Amani-Me´nou, Taabo-Cite´, and Toko-
hiri), whichwould facilitate study execution and reflect urban-
rural gradient. Based on the sampling frame, which included
those meeting the inclusion criteria in each of three strata,
we invited the participants in each stratum to the study in a
random fashion until the desired sample size (reflecting the
actual distribution in the three strata) was reached. At the
end of the study, we recruited 252, 513, and 254 from Amani-
Me´nou, Taabo-Cite´, and Tokohiri, respectively [1].
Participants had several tests (including FG, HbA1c,
malaria rapid diagnostic test (RDT), and microscopy using
EDTA-buffered venous blood). Blood, urine, and stool samples
were aliquoted into a 80 C biobank. Participants also
responded to an interviewer-administered questionnaire cov-
ering their health, socioeconomic status, and lifestyle.
Ethics approvals for the CoDuBu study were obtained from
the Ethics Committee of North-West and Central Switzerland
(reference no. 2016-00143; May 2, 2016) and the National
Ethics Committee for Research in Health of Coˆte d’Ivoire (ref-
erence no. 032/IMSHP/CNER-kp; March 24, 2017). Participants
provided written informed consent before participating in the
study. Inclusion criteria for the present analyses were (i) not
being pregnant; (ii) not taking diabetes medication; and (iii)
having complete data on all relevant covariates.
2.2. Assessment of Plasmodium infection
We used a combination of RDT and microscopy on EDTA-
buffered fasting venous blood sample to identify cases of PI.
RDTwas done using the ICT malaria dual Pf/Pan antigen test
kit (ICT Diagnostics; Cape Town, South Africa). This RDT is an
in vitro immunochromatographic assay containing two mono-
clonal antibodies (P. falciparum-specific anti-histidine-rich
protein (HRP) II and general Plasmodium anti-parasite lactate
dehydrogenase antibodies) bound on a nitrocellulose test
strip. These antibodies bind to Plasmodium antigens released
on red blood cell lysis, forming a complex that signifies a pos-
itive test [21]. All tests were done according to standard proto-
col, and were considered valid if they also had the procedural
control line. Microscopy was done by experienced laboratory
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dried, Giemsa-stained, and read under a light microscope at
high magnification to identify Plasmodium parasites. Para-
sitized blood cells were counted against 200 leukocytes (or
500 leukocytes if parasite count <10), assuming a standard
count of 8000 leukocytes per ll of blood [22]. Ten percent of
the microscope slides, selected at random, were re-read by
the senior technician for quality control, and revealed an
inter-rater agreement of 100%.
We identified participants as having PI if they had a posi-
tive RDT or identification of Plasmodium spp. on microscopy.
Since RDT can still detect HRP-II antigens a few weeks follow-
ing parasite clearance [23], we also defined microscopic PI
(limited to positive microscopy), which represents more
recent and active PI.
2.3. Assessment of glycemic control parameters
We assessed FG (mmol/l) in EDTA-buffered venous blood sam-
ple using Hemocue 201+ RT and corresponding microcuvette
(Hemocue; A¨ngelholm, Sweden) which applies an enzymatic
reaction method and photometric quantification of glucose,
and meets the International Federation of Clinical Chemistry
standards. We assessed HbA1c (%) in EDTA-buffered venous
blood using Alere Afinion AS100 analyser and HbA1c cartridge
(Alere Inc.; Waltham, MA, USA) based on boronate affinity
separation and the use of fluorescence quenching. This
method meets the performance criteria for HbA1c, according
to the ‘‘U.S. National Glycohemoglobin Standardization Pro-
gram”, with minimal interference from alternate hemoglobin
(Hb) variants or derivatives and good performance in the trop-
ics [24]. All devices were regularly controlled, microcuvettes/-
cartridges were from same respective batch, and tests were
performed according to standard protocols. Using a combina-
tion of FG, HbA1c, and questionnaire data, we defined predi-
abetes as FG 5.6–6.9 mmol/l or HbA1c 5.7–6.4% (39–
46 mmol/mol) without clinician-diagnosed diabetes, and
untreated diabetes as FG  7.0 mmol/l or HbA1c  6.5%
(48 mmol/mol) or clinician-diagnosed diabetes, without use
of diabetes medication [25].
2.4. Assessment of other covariates
We considered the following covariates measured by ques-
tionnaire: age (years), sex (male/female), formal education
(none/primary/secondary/tertiary), wealth index computed
using principal component analysis of household property
items [19], smoking status (never/former/current), frequency
of fruit intake (including seasonal and perennial fruits), and
vegetable intake (including seasonal and perennial vegeta-
bles) in raw, cooked, dried, juice, or any other form (never,
once per month, once per week, several days per week). We
also considered study area, general susceptibility to illness
(self-reported frequency of falling sick in comparison to peo-
ple of same sex and age group in the community; lower or
same frequency/higher frequency), family history of diabetes
(FHD; yes/no), and sedentary lifestyle (hours per week of
being in a sitting or lying position excluding sleeping hours).
We measured Hb in EDTA-buffered venous blood using
Hemocue 301 System (Hemocue; A¨ngelholm, Sweden) andbody temperature (three measurements, 1 min apart, highest
reading recorded) using Omron auricular thermometer
(Omron Healthcare; Kyoto, Japan). We also measured body
weight (kg), height (cm), and waist circumference (WC; cm)
using Omron weighing scale, body meter, and tape (SECA
GmbH; Hamburg, Germany), respectively, and derived body
mass index (BMI; kg/m2).
2.5. Statistical analysis
We described categorical characteristics of study participants
as counts and proportions, described continuous variables as
means and standard deviations (SD), and compared these
characteristics by FG levels. For the association between PI
as independent binary variable and glycemic control parame-
ters as endpoints, we performed linear regression models
using the continuous outcome variables FG and HbA1c in
order to differentiate the acute (stress-related glycemia) from
the longer-term (related more to diabetes development) glyce-
mic effect of PI. All regression models were adjusted incre-
mentally, for potential confounders including age, sex,
educational attainment, wealth index, and area, FHD, smok-
ing status, fruit and vegetable intake, sedentary behavior,
BMI, WC, and Hb. We assessed the stability of our models
by (i) limiting PI cases to microscopic PI; (ii) excluding partic-
ipants with potential clinical malaria defined as having PI and
either body temperature 37.5 C or anemia (Hb <120 mg/l in
females and <130 mg/l in males); (iii) mutually adjusting the
FGmodel for HbA1c and the HbA1cmodel for FG; and (iv) test-
ing dose-response relationship of parasite density with FG
and HbA1c, expressed as change in respective outcome per
unit increase in parasite density (1 unit = 1000 parasites/ll
of blood), among the microscopic PI cases.
We performed stratified analyses based on a priori-selected
potential modifiers including susceptibility to illness, body
temperature (cut-off at the median value, 36.5 C), FHD alone,
and FHD combined with having untreated diabetes (i.e., hav-
ing either FHD or untreated diabetes vs. having neither). We
tested subgroup differences by adding an interaction term
between PI and the corresponding potential modifier to the
model. The p-value of the interaction term, expressing the
statistical significance of the effect modification will be
denoted by pheterogeneity. We also limited these effect modifica-
tion analyses to microscopic PI, and tested the stability of
results to additional adjustments for HbA1c in the FG model
and for FG in the HbA1c model.
We performed all analyses with Stata version 14 (Stata
Corporation; College Station, TX, USA) and considered the
main associations and interaction terms to be statistically
significant at alpha-levels of 0.05 and 0.1, respectively. Results
are presented as beta coefficients (b) of PI positivity for FG and
HbA1c, and their 95% confidence intervals (CIs).3. Results
3.1. Summary of participants’ characteristics
For the present analyses, we excluded 20 participants with
treated clinician-diagnosed diabetes (to limit confounding of
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of clinician-diagnosed diabetes, 11 (35%) of which were
untreated and hence, were eligible for inclusion. We also
excluded 20 pregnant women, one of whom had untreated
clinician-diagnosed diabetes. This study therefore included
979 (96%) CoDuBu participants, with a male-to-female ratio
of 1.00:0.95. Mean (SD) age was 42 (13) years and 52% of partic-
ipants were older than 40 years. Half of the participants lived
in more rural areas, and 45% had no formal education. There
was a low prevalence of smoking, and fruit and vegetable
intake. Mean (SD) BMI and WC were 23 (4) kg/m2 and 80 (11)
cm respectively, and participants usually spent 33 h per week
on average being sedentary. Compared to participants with-
out elevated FG, those with elevated FG were more likely to
smoke, to have lower socioeconomic status, lower fruit and
vegetable intake, and higher BMI (Table 1).
Mean (SD) FG and HbA1c were 5.6 (1.0) mmol/l and 5.0 (0.6)
% (31 (7) mmol/mol), respectively (Table 1). Spearman correla-
tion (R) between FG and HbA1c was 0.03 (p = 0.32). Prevalence
of prediabetes and diabetes (based on the composite defini-
tion) was 46.7% and 4.3%, respectively. Prevalence of predia-
betes (45.8%) and diabetes (3.6%) based on FG was
considerably higher than the prevalence of prediabetes
(2.7%) and diabetes (0.7%) based on HbA1c (Table 1).
Ninety-nine participants (10%) had PI (RDT or microscopy)
and 55% of these were microscopic PI. Participants with ele-
vated FG had higher rates of PI than those with normal FG
(11.8% vs. 8.6%; Table 1). PI cases were mostly due to P. falci-
parum alone, with only 11% being mixed infections. Median
(IQR) parasite density among participants with microscopic
PI was 192 (3 2 0) parasites/ml of blood. Mean (SD) and median
(IQR) body temperature were 36.5 (0.5) C. There was no case
of clinical fever (range: 34.6–37.9 C) but two (2%) PI-positive
participants also had body temperature 37.5 C. Mean (SD)
Hb was 134 (16) g/l with 26 (26%) PI-positive participants hav-
ing anemia. Among the 99 PI-positive participants, 27 (27%)
had potential clinical malaria, having either anemia or body
temperature 37.5 C.
3.2. Association between PI and glycemic control
We observed statistically non-significant overall associations
between PI and glycemic control in the fully adjusted models
accounting for diabetes risk factors and Hb level. Associations
of PI with FG were generally positive and stable to adjust-
ments for potential confounders. Unadjusted estimate of dif-
ference in mean FG between PI-positives and negatives was
0.15 mmol/l (95% CI 0.06 to 0.36 mmol/l), whereas the differ-
ence in mean FG in the fully adjusted model was 0.13 mmol/l
(95% CI 0.08 to 0.33 mmol/l). The adjusted estimate of differ-
ence in mean FG remained stable to restricting PI to micro-
scopic PI, exclusion of participants with potential clinical
malaria and additional adjustment for HbA1c levels (Table 2).
We also observed a positive association between parasite
density and FG among participants with microscopic PI.
Adjusted estimate of mean FG increased by 0.09 mmol/l
(95% CI 0.14 to 0.31 mmol/l) per unit increase in parasite
density, being stronger and reaching borderline statistical sig-
nificance on additional adjustment for HbA1c (b 0.13 mmol/l,
95% CI 0.02 to 0.28 mmol/l, p = 0.08).In contrast, associations of PI with HbA1c tended to be
negative. The unadjusted estimate of difference in mean
HbA1c between PI-positives and negatives was 0.05% (95%
CI 0.18 to 0.07%) whereas the difference in mean HbA1c in
the fully adjusted model (also accounting for Hb level) was
0.02% (95% CI 0.10 to 0.14%). The adjusted estimate of differ-
ence in mean HbA1c remained on restricting PI to micro-
scopic PI and was 0.09% (95% CI 0.07 to 0.25%). This
difference became negative following the exclusion of poten-
tial clinical malaria cases (b 0.01%, 95% CI 0.15 to 0.12%)
and on additional adjustment for FG levels (b 0.02%, 95%
CI 0.13 to 0.08%) (Table 2). We also observed a negative trend
between parasite density and HbA1c among participants with
microscopic PI. Adjusted estimate of mean HbA1c decreased
by 0.03% (95% CI 0.09 to 0.08%) per unit increase in parasite
density. The negative association also became stronger and
reached borderline statistical significance on additional
adjustment for FG (b 0.07%, 95% CI 0.14 to 0.01%, p = 0.09).
3.3. Modification of associations between PI and glycemic
control
We found associations between PI and glycemic control to be
dependent on susceptibility factors. We observed statistically
significant association between PI and FG among participants
with higher illness susceptibility (b 0.34, 95% CI 0.0–0.68,
pheterogeneity = 0.140) or with body temperature >36.5 C (b
0.34, 95% CI 0.06–0.63, pheterogeneity = 0.028) or with a positive
FHD alone (b 0.88, 95% CI 0.28–1.47, pheterogeneity = 0.009) or
having either positive FHD or untreated diabetes (b 0.69,
95% CI 0.20–1.19, pheterogeneity = 0.023). Associations of micro-
scopic PI with FG showed similar trends. We also observed
statistically significant associations among participants with
higher illness susceptibility (b 0.46, 95% CI 0.02–0.91, phetero-
geneity = 0.038), with body temperature >36.5 C (b 0.34, 95%
CI 0.04 to 0.72, pheterogeneity = 0.057), a positive FHD (b 1.59,
95% CI 0.79–2.40, pheterogeneity < 0.0001) and having either pos-
itive FHD or untreated diabetes (b 1.60, 95% CI 0.88–2.32,
pheterogeneity < 0.0001) (Fig. 1). These subgroup estimates of
associations remained statistically significant in the sensitiv-
ity models additionally accounting for HbA1c levels (Table 3).
We found statistically significant positive associations of
PI with HbA1c among those with positive FHD (b 0.37, 95%
CI 0.03–0.72, pheterogeneity = 0.032). Associations of microscopic
PI with HbA1c were also statistically significant and positive
among participants with a positive FHD (b 0.59, 95% CI 0.11–
1.06, pheterogeneity = 0.025) and among those having either pos-
itive FHD or untreated diabetes (b 0.59, 95% CI 0.13–1.05,
pheterogeneity = 0.028) (Fig. 1). In contrast to FG, the interaction
patterns observed with HbA1c were obliterated in the sensi-
tivity models additionally accounting for FG levels (Table 3).
4. Discussion
In this population-based cross-sectional study, we found a
considerably higher prevalence of diabetes and particularly
pre-diabetes when defined based on FG compared to HbA1c,
suggestive of prevalent transient hyperglycemia. The high
prevalence of hyperglycemia defined based on more varying
Table 1 – Characteristics of included participants of the CoDuBu study in south-central Coˆte d’Ivoire (N = 979).
Categorical variables, n (%) All FG < 5.6 mmol/l FG  5.6 mmol/l
Sex, Men 502 (51.3) 249 (50.2) 253 (52.4)
Sex, Women 477 (48.7) 247 (49.8) 230 (47.6)
Formal education, none 441 (45.0) 194 (39.1) 247 (51.1)**
Formal education, primary 233 (23.8) 122 (24.6) 111 (23.0)
Formal education, secondary 232 (23.7) 136 (27.4) 96 (19.9)
Formal education, tertiary 73 (7.5) 44 (8.9) 29 (6.0)
Wealth tertile, T1 336 (34.3) 145 (29.2) 191 (39.6)**
Wealth tertile, T2 324 (33.1) 149 (30.0) 175 (36.2)
Wealth tertile, T3 319 (32.6) 202 (40.8) 117 (24.2)
Smoking status, never 812 (82.9) 415 (83.7) 397 (82.2)**
Smoking status, former 79 (8.1) 30 (6.0) 49 (20.1)
Smoking status, current 88 (9.0) 51 (10.3) 37 (7.7)
Fruits, never 3 (0.3) 1 (0.2) 2 (0.4)**
Fruits, once per month 259 (26.5) 112 (22.6) 147 (30.4)
Fruits, once per week 626 (63.9) 330 (66.5) 296 (61.3)
Fruits, several days per week 91 (9.3) 53 (10.7) 38 (7.9)
Vegetables, never 130 (13.3) 35 (7.1) 95 (19.7)**
Vegetables, once per month 260 (26.6) 133 (26.8) 127 (26.3)
Vegetables, once per week 452 (46.2) 246 (49.6) 206 (42.6)
Vegetables, several days per week 137 (14.0) 82 (16.5) 55 (11.4)
Study area: Taabo-Cite´ 487 (49.7) 308 (62.1) 179 (37.1)**
Study area: Amani-Me´nou 240 (24.5) 44 (8.9) 196 (40.6)
Study area: Tokohiri 252 (25.8) 144 (29.0) 108 (22.3)
Rural area 492 (50.3) 188 (37.9) 304 (62.9)**
Urban area 487 (49.7) 308 (62.1) 179 (37.1)
Higher susceptibility to illness 426 (43.5) 196 (39.5) 230 (47.6)**
Family history of diabetes 107 (10.9) 52 (10.5) 55 (11.4)
Anemia 202 (20.6) 112 (22.6) 90 (18.6)
Body temperature 37.5 C 17 (1.7) 7 (1.4) 10 (2.1)
Plasmodium infection (rapid diagnostic test, RDT-PI) 95 (9.7) 41 (8.3) 54 (11.2)
Plasmodium infection (microscopy, microscopic PI) 54 (5.5) 25 (5.0) 29 (6.0)
Plasmodium infection (RDT-PI or microscopic PI) 99 (10.1) 42 (8.5) 57 (11.8)*
Prediabetes (fasting glucose, FG-based) 448 (45.8) 0 (0) 448 (100)**
Prediabetes (glycated hemoglobin, HbA1c-based) 26 (2.7) 13 (2.6) 13 (2.7)
Prediabetes (FG-based or HbA1c-based) 457 (46.7) 13 (2.6) 444 (91.9)**
Diabetes (FG-based) 35 (3.6) 0 (0) 35 (100)**
Diabetes (HbA1c-based) 7 (0.7) 0 (0) 7 (100)**
Diabetes (self-reported clinician diagnosis) 10 (1.0) 3 (0.6) 7 (1.5)
Diabetes (FG-based or HbA1c-based or clinician-diagnosis) 42 (4.3) 3 (0.6) 39 (8.1)**
Continuous variables, mean (SD)
Age (years) 41.9 (13) 41.3 (13) 42.5 (13)
Body mass index (kg/m2) 23.3 (4) 23.6 (4) 23.0 (4)**
Waist circumference (cm) 80.4 (11) 80.7 (12) 80.0 (10)
Body temperature (C) 36.5 (0.5) 36.5 (0.5) 36.5 (0.5)
Sedentary behavior (hours/week) 32.5 (17) 32.5 (17) 32.6 (17)
Hemoglobin (Hb, mg/l) 134 (16) 134 (16) 134 (15)
Plasmodium parasite density (per ml) 547 (1735) 250 (2 3 8) 804 (2345)
Fasting glucose (FG, mmol/l) 5.6 (1) 5.0 (0.4) 6.2 (1.1)**
Glycated hemoglobin (HbA1c, % (mmol/mol)) 5.0 (0.6) (31 (7)) 5.0 (0.4) (31 (4)) 5.0 (0.7) (31 (8))
CoDuBu: Coˆte d’Ivoire Dual Burden of Disease study. FG: fasting glucose. Prediabetes was defined as fasting glucose 5.6–6.9 mmol/l or glycated
hemoglobin 5.7–6.4% (39–46 mmol/mol) without clinician-diagnosed diabetes. Diabetes was defined as fasting glucose 7.0 mmol/l or glycated
hemoglobin 6.5% (48 mmol/mol) or self-reported clinician-diagnosed diabetes. Rural area comprises Amani-Me´nou and Tokohiri whereas
urban area comprises Taabo-Cite´. Anemia was defined as Hb <130 mg/l in males and <120 mg/l in females. Higher susceptibility to illness was
defined as a self-report of falling sick more frequently than people in the same age and sex group in the community. Summary estimates for
Plasmodium parasite density were limited to the microscopic PI-positive participants.
* P-value of the difference in variable summary estimates between the FG groups <0.1.
**
Respective p-value <0.05. Differences in categorical and continuous variables were tested using the v2 test and t-test, respectively.
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tions such as malaria in the tropical setting studied here.
Indeed, we observed that asymptomatic PI was independently
and positively associated with FG, but not HbA1c, in the pres-ence of parameters suggestive of a setting characterized by
more acute malarial infections (i.e., positive microscopic PI)
or of an increased susceptibility to stress hyperglycemia
(e.g., elevated temperature, higher susceptibility to symp-
Table 2 – Incrementally adjusted associations between Plasmodium infection and glycemic control in the CoDuBu study in
south-central Coˆte d’Ivoire.
Fasting glucose, FG (mmol/l) Glycated hemoglobin, HbA1c (%)
Estimate b (95% CI) b (95% CI)
Model 2 0.17 (0.06 to 0.38) 0.03 (0.15 to 0.10)
Model 3 0.13 (0.08 to 0.33) 0.01 (0.13 to 0.12)
Model 4 0.12 (0.09 to 0.33) 0.01 (0.13 to 0.11)
Model 5 0.11 (0.10 to 0.31) 0.01 (0.14 to 0.11)
Model 6 0.12 (0.08 to 0.33) 0.01 (0.11 to 0.13)
Model 7a 0.13 (0.08 to 0.33) 0.02 (0.10 to 0.14)
Model 7b, RDT-PI 0.13 (0.08 to 0.34) 0.004 (0.12 to 0.13)
Model 7c, microscopic PI 0.09 (0.19 to 0.36) 0.09 (0.07 to 0.25)
Model 8 0.07 (0.16 to 0.30) 0.01 (0.15 to 0.12)
Model 9 0.11 (0.06 to 0.29) 0.02 (0.13 to 0.08)
CoDuBu: Coˆte d’Ivoire Dual Burden of Disease study. Plasmodium infection (PI) was defined as a positive malaria rapid diagnostic test or the
microscopic identification of Plasmodium species. All beta-coefficients and 95% confidence intervals (CIs) derive from linear regression models
excluding participants with treated diabetes, and represent increase or decrease in the mean of respective outcome in Plasmodium positive vs.
negative participants. RDT-PI: Plasmodium infection defined as positive rapid diagnostic test. Microscopic PI: Plasmodium infection defined as
positive microscopy. All models had sample size of 979 except model 8 where sample size was 952.
Model 1: Unadjusted.
Model 2: Model 1 + age and sex.
Model 3: Model 2 + educational level, wealth index, and area.
Model 4: Model 3 + family history of diabetes.
Model 5: Model 4 + smoking status, frequency of fruit and vegetable intake, and sedentariness.
Model 6: Model 5 + body mass index and waist circumference.
Model 7a: Model 6 + hemoglobin level (primary model).
Model 7b: Model 7a with PI defined only as positive RDT.
Model 7c: Model 7a with PI defined only as positive microscopy.
Model 8: Model 7a, excluding participants with potential clinical malaria (defined as having PI and either anemia or body temperature  37.5 C).
Model 9: Model 7a, mutually adjusted i.e., FG model additionally adjusted for HbA1c, and vice versa.
6 d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 6 ( 2 0 1 9 ) 1 0 7 8 4 5tomatic infection, family history of diabetes, or presence of
diabetes).
Suggestive evidence for the potential role of PI on more
acute glucose derangements has been described. The inflam-
matory nature of PI promotes physiological stress, which may
result in hyperglycemia. PI was shown to stimulate the pro-
motion of inflammatory cytokines [7,10,26] and the activation
of NLRP3 inflammasome [8], among other pathways. Indeed,
these inflammatory markers could be a cause or direct conse-
quence of hyperglycemia or diabetes [9]. PI is reported to
increase permeability of gastric and intestinal linings to
sucrose [27]. Compared to controls, adult patients with
uncomplicated PI in a hospital-based study exhibited a 25%
increase in glucose production, with parallel and significant
increases in gluconeogenesis, counter-regulatory hormones,
and inflammatory profiles [26]. Another study observed
increases in FG, HbA1c, and insulin resistance during uncom-
plicated malaria in participants without diabetes. However, in
this study, the positive associations with HbA1c had not been
adjusted for FG, potentially explaining the difference in
results for HbA1c. Interestingly, the reported insulin resis-
tance was not compensated by insulin levels, suggesting a
greater risk of diabetes following repeated PI [28].
The observed cross-sectional association between the
presence of asymptomatic PI and hyperglycemia warrants
future well-designed longitudinal studies to (i) follow-up par-
ticipants (without PI) with and without diabetes for the inci-
dence of new PI over a defined time period and (ii) follow-up
participants (without diabetes) to see whether those withhighest rates of PI and largest glycemic response are the ones
at highest risk of developing clinical diabetes. Stated differ-
ently, longitudinal studies should test whether a hyper-
glycemia reaction in response to repeated or chronic
infection is informing on the long-term diabetes risk, includ-
ing age of diabetes onset. If in longitudinal studies, repeated
PI infections are linked with a younger age of onset of dia-
betes, an adaptation of the target population for diabetes
screening may be warranted in LMICs. Maternal malaria has
in fact been associated with markers of insulin resistance in
their babies [29]. Interestingly, these markers were also asso-
ciated with low birth weight [29], which predisposes affected
babies to metabolic diseases in later-life [30]. A considerable
overlap between malaria and cardio-metabolic risk factors
was also reported in African adolescents [31], and those
who had in utero malaria exposure had raised FG levels [13].
Genetically determined susceptibility to a pro-inflammatory
response should be tested for effect modification.
Our findings are of direct clinical and public health rele-
vance. First, they point to current knowledge gaps on the
potential influence of asymptomatic PI on glycemic control.
Second, the observed association of PI and hyperglycemia
emphasize the need for adapting health services toward more
cost-effective integrated care in endemic countries facing a
rapidly growing dual disease burden [32]. Third, if the tran-
sience of PI-related hyperglycemia is confirmed by longitudi-
nal studies, this will expose the need for improvements in the
estimation of diabetes prevalence in malaria-endemic set-
tings and for the right time point for diagnosing an underlying
Fig. 1 – Modification of the association between Plasmodium infection (RDT or microscopy-diagnosed vs. microscopy-
diagnosed) and glycemic control by different susceptibility factors, in the CoDuBu study in south-central Coˆte d’Ivoire.
CoDuBu: Coˆte d’Ivoire Dual Burden of Disease study. PI: Plasmodium infection. RDT: rapid diagnostic test. All beta-coefficients
and 95% confidence intervals (CIs) derive from multivariable linear regression models excluding participants with treated
diabetes, and represent increase or decrease in the mean of respective outcome in PI-positive vs. PI-negative participants. All
models were adjusted for age, sex, educational level, wealth index, area, family history of diabetes, smoking status,
frequency of fruit and vegetable intake, sedentariness, body mass index, waist circumference, and hemoglobin level. PI was
defined as a positive malaria RDT or the microscopic identification of Plasmodium species. DM: diabetes mellitus. N = 979; n
(illness susceptibility, high) = 426; n (body temperature > 36.5 C) = 458; n (family DM history, yes) = 107; n (family DM history
or DM, yes) = 143. *Pheterogeneity < 0.1; **Pheterogeneity < 0.05; ***Pheterogeneity < 0.0001.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 6 ( 2 0 1 9 ) 1 0 7 8 4 5 7DM. This will involve the identification of most effective tests
given the limitations of FG and HbA1c [33], and further explo-
ration of the utility of oral glucose tolerance test (OGTT) and
glycated albumin or their combinations in these settings
[34]. In line with recent findings with tuberculosis [14], diag-
nostic testing for any underlying diabetes may need to be
postponed to after malaria treatment or clearance of residual
PI.
The strengths of our study include being the first
population-based investigation shedding light on a direct link
between asymptomatic PI and both short- and longer-term
markers of glycemic control. We defined PI as a composite
measure limiting exposure misclassification. We could con-
trol for several diabetes risk factors and explore effect modi-
fications given the detailed phenotypic characterization of
the cohort participants. The assessment of effect modifica-
tion allowed confirming hypothesized susceptibility patterns
in this population. The population-based setting of our study
allowed the investigation of the impact of asymptomatic PI,which is quite prevalent in malaria-endemic areas, and these
findings could be translated to similar settings undergoing
epidemiological transition.
The major limitation of our study is its cross-sectional nat-
ure, precluding any inferences on direction of associations or
causality. Although we applied RDT and microscopy for PI
diagnosis, we may have missed some cases that we could
have detected with more sensitive diagnostic tests, such as
polymerase chain reaction (PCR). However, this potential mis-
classification has most likely biased our results toward null.
We could not investigate associations with confirmed predia-
betes or diabetes given the lack of OGTT in this study. Larger
longitudinal studies including a PCR diagnosis of PI, and dif-
ferent diabetes tests would improve the understanding of
the impact of PI on glycemic control and on underlying dia-
betes in LMICs.
In conclusion, asymptomatic PI in this malaria-endemic
setting of south-central Coˆte d’Ivoire was associated with gly-
cemic derangements, in conditions of background subclinical
Table 3 – Sensitivity analyses on the modification of the association between Plasmodium infection (RDTor microscopy-diagnosed vs. microscopy-diagnosed) and glycemic
control by different susceptibility factors using mutually adjusted models (i.e., fasting glucose models additionally adjusted for glycated hemoglobin and vice versa), in the
CoDuBu study in south-central Coˆte d’Ivoire.
RDT or microscopy Microscopy
Fasting glucose (mmol/l) Glycated hemoglobin (%) Fasting glucose (mmol/l) Glycated hemoglobin (%)
Variable Categories N b (95% CI) b (95% CI) b (95% CI) b (95% CI)
All 979 0.11 (0.06–0.29) 0.02 (0.13–0.08) 0.01 (0.22–0.29) 0.06 (0.08–0.20)
Susceptibility to illness Low 551 0.01 (0.21–0.24) 0.0002 (0.13–0.13) 0.19 (0.48–0.11) 0.10 (0.07–0.28)
High 426 0.29 (0.0–0.58)** 0.04 (0.22–0.13) 0.34 (0.04–0.73)* 0.02 (0.23–0.22)
Pheterogeneity 0.140 0.684 0.031 0.457
Body temperature 36.5 C 521 0.09 (0.35–0.16) 0.01 (0.14–0.16) 0.19 (0.52–0.15) 0.06 (0.14–0.25)
>36.5 C 458 0.29 (0.05–0.54)** 0.05 (0.19–0.10) 0.19 (0.13–0.52) 0.07 (0.12–0.26)
Pheterogeneity 0.030 0.583 0.110 0.945
Family history of diabetes No 872 0.05 (0.13–0.24) 0.04 (0.15–0.07) 0.12 (0.37–0.12) 0.05 (0.09–0.20)
Yes 107 0.55 (0.04–1.06)** 0.11 (0.19–0.41) 1.08 (0.39–1.78)** 0.11 (0.30–0.52)
Pheterogeneity 0.075 0.351 0.001 0.807
Family history or diabetes diagnosisa No 836 0.08 (0.09–0.26) 0.03 (0.14–0.09) 0.06 (0.28–0.17) 0.05 (0.09–0.20)
Yes 143 0.53 (0.10–0.97)** 0.002 (0.28–0.28) 1.16 (0.52–1.80)*** 0.10 (0.31–0.59)
Pheterogeneity 0.056 0.869 <0.001 0.831
CoDuBu: Coˆte d’Ivoire Dual Burden of Disease study. All beta-coefficients and 95% confidence intervals (CIs) derive from multivariable linear regression models excluding participants with treated
diabetes, and represent increase or decrease in the mean of respective outcome in Plasmodium positive vs. negative participants. All models were adjusted for age, sex, educational level, wealth index,
area, family history of diabetes, smoking status, frequency of fruit and vegetable intake, sedentariness, body mass index, waist circumference, and hemoglobin level. Fasting glucose models were
additionally adjusted for glycated hemoglobin and glycated hemoglobin models were additionally adjusted for fasting glucose. Plasmodium infection was defined as a positive malaria rapid diagnostic
test (RDT) or the microscopic identification of Plasmodium species.
a Combines family history of diabetes and diabetes diagnosis into one variable where participants with neither family history of diabetes nor diabetes diagnosis were designated no whereas those
with either component were designated yes.
* P < 0.1.
** P < 0.05.
*** P < 0.0001.
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d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 5 6 ( 2 0 1 9 ) 1 0 7 8 4 5 9inflammation. For a better estimation of diabetes burden and
targeted diabetes control in LMICs, improvements in diagnos-
tics and postponement of diabetes diagnosis in the presence
of PI are warranted. These findings need confirmation by lon-
gitudinal studies, which should determine whether these gly-
cemic derangements put persons at risk for clinical diabetes
in the longer term and whether PI is a risk factor not only
for hyperglycemia, but also for diabetes.
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